Nature’s Pharmacy: Plant-Based Antifungal Agents and Their Therapeutic Potential

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 3 | 01 | Page :
    By

    Ashish Yadav,

  • Himanshu Singh,

  • Rajkamal,

  • Nitish Kumar,

  • Raveena Rani,

  1. Student, Department Of Pharmacy, Dasmesh College Of Pharmacy, Faridkot, Punjab, India
  2. Student, Department Of Pharmacy, Dasmesh College Of Pharmacy, Faridkot, Punjab, India
  3. Student, Department Of Pharmacy, Dasmesh College Of Pharmacy, Faridkot, Punjab, India
  4. Student, Department Of Pharmacy, Dasmesh College Of Pharmacy, Faridkot, Punjab, India
  5. Assistant Professor, Department Of Pharmacy, Dasmesh College Of Pharmacy, Faridkot, Punjab, India

Abstract

Antifungal resistance has increased dramatically over the last 10 years, causing serious problems for healthcare because of higher morbidity and death. The urgent need for new treatments is highlighted by the scarcity of effective antifungal medications, their toxicity, and the rise of resistant strains. Since many plants have bioactive secondary metabolites with strong antifungal qualities, including alkaloids, flavonoids, terpenoids, phenolics, and saponins, ethnobotanical sources offer a viable path. Plants with notable antifungal action, such as Bridelia retusa, Hypoestes serpens, and Piper crassinervium, have been used in traditional medicine. These phytochemicals work by causing oxidative stress, blocking ergosterol synthesis, and rupturing fungal membranes. Recent developments in nanotechnology have improved the clinical potential of plant-derived chemicals by increasing their stability, bioavailability, and targeted delivery. Nevertheless, issues with bioavailability, standardization, and regulatory approval still exist. Finding safe, efficient, and long-lasting antifungal medicines to counteract growing resistance may be made easier by combining ethnobotanical knowledge with contemporary scientific study.

Keywords: Antifungal resistance, Bridelia retusa, Flavonoids, Hypoestes serpens, nanotechnology, phytochemicals, Piper crassinervium, Plant-derived antifungal agents, Terpenoids

How to cite this article:
Ashish Yadav, Himanshu Singh, Rajkamal, Nitish Kumar, Raveena Rani. Nature’s Pharmacy: Plant-Based Antifungal Agents and Their Therapeutic Potential. International Journal of Tropical Medicines. 2026; 03(01):-.
How to cite this URL:
Ashish Yadav, Himanshu Singh, Rajkamal, Nitish Kumar, Raveena Rani. Nature’s Pharmacy: Plant-Based Antifungal Agents and Their Therapeutic Potential. International Journal of Tropical Medicines. 2026; 03(01):-. Available from: https://journals.stmjournals.com/ijtm/article=2026/view=240520


References

1. Beck-Sague C, Banerjee S, Jarvis WR. Epidemiology of nosocomial infections. Journal of Public Health. 1993;83:1739–1745. 2. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrobial Agents and Chemotherapy. 1995;39(1):1–8. 3. Jayasinghe L, Kumarihamy BMM, Jayarathna KHRN, Udishani NWMG, Bandara BMR, Hara N, Fujimoto Y. Antifungal constituents of the stem bark of Bridelia retusa. Phytochemistry. 2003;62(4):637–641. 4. Ayurvedic Medicinal Plants Database. Available from: http://ayurvedicmedicinalplants.com. Accessed May 2008. 5. Singh UV, Ahlawat SP, Bisht NS. Nursery techniques of local tree species-II. SFRI Information Bulletin No. 11. State Forest Research Institute, Department of Environment and Forests, Government of Arunachal Pradesh, Itanagar, India; 2003. Available from: http://sfri.nic.in/pdf_files/Nursery%20Techniques%20of%20Local%20Tree%20Species%20II.pdf 6. Borris RP. Natural products research: perspectives from a major pharmaceutical company. Journal of Ethnopharmacology. 1996;51(1-3):29–38. 7. Lewis WH, Elvin-Lewis MP. Medicinal plants as sources of new therapeutics. Annals of the Missouri Botanical Garden. 1995;82:16–24. 8. Schultes RE. The kingdom of plants. In: Thomson WAR, editor. Medicines from the Earth. New York: McGraw- Hill Book Company; 1978. p. 208. 9. Jung HJ, Sung WS, Yeo SH, Kim HS, Lee IS, Woo ER, Lee DG. Antifungal activity of plant extracts. Archives of Pharmacal Research. 2006;29(9):746–751. 10. Cafarchia C, De Laurentis N, Milillo MA, Losacco V, Puccini V. Antifungal activity of selected essential oils. Parassitologia. 2002;44:153–156. 11. Cowan MM. Plant products as antimicrobial agents. Clinical Microbiology Reviews. 1999;12(4):564–582. 12. Sunthitikawinsakul A, Kongkathip N, Kongkathip B, Phonnakhu S, Daly JW, Spande TF, Nimit Y, Rochanaruangrai S. Bioactive alkaloids from medicinal plants. Planta Medica. 2003;69:155–159. 13. Reina M, Coloma AG, Díaz DD, Cabrera R, Mariño CG, Rodríguez ML, Villarroel L. Natural antifungal agents from medicinal plants. Natural Product Research. 2006;20(1):13–19. 14. Rahalison L, Benathan M, Monod M, Frenk E, Gupta MP, Solis PN, Fuzzati N, Hostettmann K. Antifungal principles from medicinal plants. Planta Medica. 1995;61(4):360–362. 15. Chaurasia SC, Vyas KK. Antimicrobial studies of medicinal plants. Journal of Research in Indian Medicine, Yoga and Homeopathy. 1977;24:45–50. 16. Shin S, Kang CA. Antifungal activity of plant essential oils. Letters in Applied Microbiology. 2003;36(2):111–115. 17. Belhouchet Z, Sautour M, Miyamoto T, Lacaille-Dubois MA. Antifungal saponins from plants. Chemical and Pharmaceutical Bulletin (Tokyo). 2008;56:1324–1328. 18. Escalante AM, Santecchia CB, Lopez SN, Gattuso MA, Gutierrez Ravelo A, Delle Monache A, Gonzalez Sierra M, Zacchino SA. Antifungal activity of plant extracts. Journal of Ethnopharmacology. 2002;82:29–34. 19. Zhang JD, Cao YB, Xu Z, Sun HH, An MM, Yan L, Chen HS, Gao PH, Wang Y, Jia XM, Jiang YY. Antifungal properties of natural compounds. Biological and Pharmaceutical Bulletin. 2005;28:2211–2215. 20. Wang F, Yang D, Ren S, Zhang H, Li R. Antifungal constituents from medicinal plants. Journal of Chinese Medicinal Materials. 1999;22:400–404. 21. Jayaweera DMA. Medicinal plants (indigenous and exotic) used in Ceylon. Part II. Colombo: National Science Council of Sri Lanka; 1982. 22. Adhav M, Solanki CM, Patel B, Gharia A. Evaluation of isoflavanone as an antimicrobial agent from leaves of Bridelia retusa. Oriental Journal of Chemistry. 2002;18:Abstract 228. 23. Mehare ID, Hatapakki BL. Antiinflammatory activity of bark of Bridelia retusa. Indian Journal of Pharmaceutical Sciences. 2003;65:410–411. 24. Rasoamiaranjanahary L, Marston A, Guilet D, Schenk K, Randimbivololona F, Hostettmann K. Antifungal diterpenes from Hypoestes serpens. Phytochemistry. 2003;62:333–337. 25. Rasoamiaranjanahary L, Guilet D, Marston A, Randimbivololona F, Hostettmann K. Antifungal isopimaranes from Hypoestes serpens. Phytochemistry. 2003;64:543–548. 26. ZipcodeZoo Database. Hypoestes serpens plant information. Available from: http://zipcodezoo.com/Plants/H/Hypoestes_serpens.asp. Accessed May 2008. 27. Andriamihaja B, Martin MT, Rasoanaivo P, Frappier F. A new diterpene from Hypoestes serpens. Journal of Natural Products. 2001;64:217–218. 28. Yuncker TG. The Piperaceae of Brazil. Hoehnea. 1972;2:19–366. 29. ZipcodeZoo Database. Piper crassinervium information. Available from: http://zipcodezoo.com/Plants/P/piper_crassinervium.asp. Accessed May 2008. 30. Mabberley DJ. The Plant-Book: A portable dictionary of the higher plants. Cambridge: Cambridge University Press; 1997. 31. Joly AB. Introdução à Taxonomia Vegetal. São Paulo: Editora Nacional; 1985. 32. Yamaguchi LF, Lago JHG, Tanizaki TM, Mascio PD, Kato MJ. Antioxidant activity of compounds from Piper crassinervium. Phytochemistry. 2006;67:1838–1843. 33. Vallabhaneni S, Cleveland AA, Farley MM, et al. Epidemiology of echinocandin nonsusceptible Candida glabrata bloodstream infections. Open Forum Infectious Diseases. 2015;2(4):ofv163. 34. Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole resistance in Aspergillus fumigatus. Clinical Infectious Diseases. 2016;62(3):362–368. 35. Rivero-Menendez O, Alastruey-Izquierdo A, Mellado E, Cuenca-Estrella M. Triazole resistance in Aspergillus species. Journal of Fungi. 2016;2(3):21. 36. Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in bloodstream infections. Indian Journal of Medical Research. 2012;136(6):997–1003. 37. Nigussie D, Davey G, Tufa TB, Brewster M, Legesse BA, Fekadu A, Makonnen E. Antibacterial and antifungal activities of Ethiopian medicinal plants: a systematic review. Frontiers in Pharmacology. 2021;12:633921. 38. Ko HS, Taguchi H, Takizawa K, Fukushima K, Kim HS. Enzymatic mechanisms in zygomycosis-causing Mucorales. Korean Journal of Medical Mycology. 2007;12(1):9–15. 39. Chukwuebuka EO, Chukwuma OC, Obaje EG, Agbo UM, Okoye NC. Medicinal plants in antifungal drug discovery. Journal of Medical Imaging and Infection. 2024;12(3):163. 40. Zia Q, Khan AA, Zubair S, Owais M. Nanoformulated phytochemicals for antifungal therapy. Journal of Neonatal Surgery. 2025;14(2):2256. 41. Kumar A. Plant-derived antifungal agents: challenges in clinical trials. Journal of Asian Natural Products Research. 2025;27(8):1–10.

Ahead of Print Subscription Review Article
Volume 03
01
Received 16/12/2025
Accepted 22/12/2025
Published 20/01/2026
Publication Time 35 Days
27

Login


My IP

PlumX Metrics